Copyright
©2014 Baishideng Publishing Group Inc.
World J Nephrol. Aug 6, 2014; 3(3): 77-84
Published online Aug 6, 2014. doi: 10.5527/wjn.v3.i3.77
Published online Aug 6, 2014. doi: 10.5527/wjn.v3.i3.77
Table 1 Summary of the critical slit diaphragm and the novel slit diaphragm associated molecules
Ref. | Molecules | Predicted molecule weight | Functions in the slit diaphragm |
Schnabe et al[26] | ZO-1 | 225 kDa | Interact with NEPH1 |
Kestilä et al[3] | Nephrin | 180 kDa | Maintaining the barrier function |
Schwarz et al[34] | Podocin | 42 kDa | A raft-associated component and interact with nephrin and CD2AP |
Shih et al[6] | CD2AP | 80 kDa | Interact with nephrin and anchor nephrin to the cytoskeleton |
Liu et al[37] | NEPH1 | 110 kDa | Interact with ZO-1 and nephrin |
Winn et al[9], Reiser et al[10] | TRPC6 | About 110 kDa | Interact with nephrin and podocin |
Miyauchi et al[45] | SV2B | 80 kDa | The proper arrangement of CD2AP |
Hashimoto et al[46] | Ephrin-B1 | 50 kDa | Maintaining the slit diaphragm structure |
Saito et al[47] | Neurexin | 150 kDa | Regulating the slit diaphragm function |
- Citation: Fukusumi Y, Miyauchi N, Hashimoto T, Saito A, Kawachi H. Therapeutic target for nephrotic syndrome: Identification of novel slit diaphragm associated molecules. World J Nephrol 2014; 3(3): 77-84
- URL: https://www.wjgnet.com/2220-6124/full/v3/i3/77.htm
- DOI: https://dx.doi.org/10.5527/wjn.v3.i3.77